IRIS
MORETTA, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 60.021
AS - Asia 5.072
NA - Nord America 2.191
SA - Sud America 375
AF - Africa 85
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 1
Totale 67.749
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 59.081
SG - Singapore 2.362
US - Stati Uniti d'America 2.038
CN - Cina 1.353
VN - Vietnam 822
FR - Francia 487
BR - Brasile 250
HK - Hong Kong 185
FI - Finlandia 109
DE - Germania 93
MX - Messico 70
JP - Giappone 68
CH - Svizzera 65
CA - Canada 51
GB - Regno Unito 51
AR - Argentina 50
BD - Bangladesh 44
IN - India 36
NL - Olanda 32
IQ - Iraq 31
PH - Filippine 28
ID - Indonesia 27
EC - Ecuador 19
ZA - Sudafrica 17
PK - Pakistan 16
RU - Federazione Russa 16
TH - Thailandia 15
CO - Colombia 12
IE - Irlanda 12
MA - Marocco 12
UZ - Uzbekistan 11
VE - Venezuela 11
CR - Costa Rica 10
PY - Paraguay 10
CL - Cile 9
ES - Italia 9
DZ - Algeria 8
KE - Kenya 8
PE - Perù 8
SA - Arabia Saudita 8
UA - Ucraina 8
RO - Romania 7
TW - Taiwan 7
EG - Egitto 6
JO - Giordania 6
MY - Malesia 6
TN - Tunisia 6
AL - Albania 5
AT - Austria 5
BG - Bulgaria 5
PL - Polonia 5
PT - Portogallo 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
AZ - Azerbaigian 4
GA - Gabon 4
GT - Guatemala 4
IR - Iran 4
JM - Giamaica 4
OM - Oman 4
PS - Palestinian Territory 4
SN - Senegal 4
TR - Turchia 4
AO - Angola 3
AU - Australia 3
BO - Bolivia 3
LB - Libano 3
MM - Myanmar 3
NI - Nicaragua 3
NP - Nepal 3
TT - Trinidad e Tobago 3
BB - Barbados 2
BY - Bielorussia 2
CD - Congo 2
CG - Congo 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DJ - Gibuti 2
GF - Guiana Francese 2
GR - Grecia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
LT - Lituania 2
ML - Mali 2
NO - Norvegia 2
SI - Slovenia 2
SV - El Salvador 2
TL - Timor Orientale 2
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BW - Botswana 1
EE - Estonia 1
ET - Etiopia 1
GH - Ghana 1
HU - Ungheria 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
LC - Santa Lucia 1
Totale 67.731
Salva come PNG Salva come JPEG
Città #
Genova 40.047
Genoa 10.847
Rapallo 4.521
Vado Ligure 3.395
Singapore 1.089
San Jose 837
Lauterbourg 460
Ho Chi Minh City 242
New York 179
Ashburn 175
Hanoi 175
Beijing 174
Hong Kong 172
Helsinki 109
Bordighera 108
Frankfurt am Main 83
Santa Clara 83
Council Bluffs 75
Tokyo 65
Zurich 65
Mexico City 46
Haiphong 39
Da Nang 36
Los Angeles 36
Milan 36
Tianjin 33
Amsterdam 21
Des Moines 19
Shanghai 17
Biên Hòa 16
Baghdad 15
Chicago 15
City of London 15
Montreal 15
Orem 15
Rome 14
Dallas 13
Bangkok 12
Hải Dương 12
Ninh Bình 12
Phoenix 12
São Paulo 12
Cardiff 11
Dublin 11
San Francisco 11
Mumbai 10
Atlanta 9
Brasília 9
Johannesburg 9
San José 9
Tashkent 9
Toronto 9
Can Tho 8
London 8
Valenza 8
Buffalo 7
Denver 7
Dhaka 7
Guangzhou 7
Jakarta 7
Nairobi 7
Paris 7
Seattle 7
Amman 6
Chennai 6
Hưng Yên 6
Lima 6
Manchester 6
Porto Alegre 6
Quận Ba 6
Thái Nguyên 6
Vĩnh Long 6
Washington 6
Bắc Ninh 5
Charlotte 5
Guayaquil 5
Karachi 5
Marseille 5
Medellín 5
Nuremberg 5
Quảng Ngãi 5
Ribeirão das Neves 5
Rio de Janeiro 5
Thái Bình 5
Wuhan 5
Baku 4
Buenos Aires 4
Bắc Giang 4
Caracas 4
Dakar 4
Florence 4
Guarulhos 4
Ha Long 4
Hangzhou 4
Houston 4
Kyiv 4
Lahore 4
Madrid 4
Manila 4
Naples 4
Totale 63.719
Salva come PNG Salva come JPEG
Nome #
Analysis of natural killer cells isolated from human decidua: Evidence that 2B4 (CD244) functions as an inhibitory receptor and blocks NK-cell function 253
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 246
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 234
Activating KIRs and NKG2C in viral infections: Toward NK cell memory? 231
Antibodies to adhesion molecules inhibit the lytic function of MHC-unrestricted cytotoxic cells by preventing their activation. 227
New miRNA signature heralds human NK cell subsets at different maturation steps: Involvement of miR-146a-5p in the regulation of KIR expression 227
Analysis of the receptor-ligand interactions in the natural killer-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias: evidence for the involvement of the Poliovirus receptor (CD155) and Nectin-2 (CD112) 222
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 222
Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis 214
GPR56 as a novel marker identifying the CD56dull CD16+ NK cell subset both in blood stream and in inflamed peripheral tissues. 212
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 212
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 211
2B4 functions as a co-receptor in human NK cell activation 209
NK Cells Mediate a Crucial Graft-versus-Leukemia Effect in Haploidentical-HSCT to Cure High-Risk Acute Leukemia 204
Bridging innate NK cell Functions with Adaptive Immunity. 202
Late development of FcεRγneg adaptive natural killer cells upon human cytomegalovirus reactivation in umbilical cord blood transplantation recipients 202
M-CSF induces the expression of a membrane-bound form of IL-18 in a subset of human monocytes differentiating in vitro toward macrophages 201
IL-12 or IL-4 prime human NK cells to mediate functionally divergent interactions with dendritic cells or tumors 200
Features of Memory-Like and PD-1+ Human NK Cell Subsets 198
Uptake of CCR7 by KIR2DS4⁺ NK cells is induced upon recognition of certain HLA-C alleles 198
A novel surface molecule homologous to the p58/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation. 198
NK/DC crosstalk in anti-viral response. 197
CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. 195
B cell growth factor activity of immunoaffinity-purified and recombinant human interleukin 2. 192
Human NK cell receptors/markers: A tool to analyze NK cell development, subsets and function. 192
Characterization of CD56-/CD16+ natural killer (NK) cells: A highly dysfunctional NK subset expanded in HIV-infected viremic individuals. 189
X-linked lymphoproliferative disease: the dark side of 2B4 function. 187
Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias 187
Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells 186
Haploidentical Haematopoietic Stem Cell Transplantation: Role of NK Cells and Effect of Cytomegalovirus Infections 186
TLR-stimulated neutrophils instruct NK cells to trigger dendritic cell maturation and promote adaptive T cell responses 185
Function and specificity of human natural killer cell receptors. 185
KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing 185
Analysis of natural killer cells in TAP2-deficient patients: expression of functional triggering receptors and evidence for the existence of inhibitory receptor(s) that prevent lysis of normal autologous cells 184
Nidogen-1 is a novel extracellular ligand for the NKp44 activating receptor 184
Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? 183
A monoclonal antibody specific for a common determinant of the human T cell receptor gamma/delta directly activates CD3+WT31- lymphocytes to express their functional program(s). 183
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. 183
A novel mechanism of antitumor response involving the expansion of CD3+/CD56+ large granular lymphocytes triggered by a tumor-expressed activating ligand. 182
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 182
CD45-mediated regulation of LFA1 function in human natural killer cells. Anti-CD45 monoclonal antibodies inhibit the calcium mobilization induced via LFA1 molecules. 181
Analysis of NK cell/DC interaction in NK-type lymphoproliferative disease of granular lymphocytes (LDGL): role of DNAM-1 and NK p30 180
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 179
Evidence that the KIR2DS5 gene codes for a surface receptor triggering natural killer cell function. 179
Markers and function of human NK cells in normal and pathological conditions 179
Human NK Cell Subsets Redistribution in Pathological Conditions: A Role for CCR7 Receptor 178
NK cells and their receptors during viral infections. 177
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 177
Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors. 176
NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy? 174
Activation of human NK cells by plasmacytoid dendritic cells and its modulation by CD4 + T helper cells and CD4 + CD25hi T regulatory cells 174
Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. 173
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 173
Learning how to discriminate between friends and enemies,a lesson from Natural Killer cells 172
Homophilic interaction of NTBA, a member of the CD2 molecular family: induction of cytotoxicity and cytokine release in human NK cells 172
A high-resolution view of NK-cell receptors: structure and function. 171
Identification of NKp80, a novel triggering molecule expressed by human NK cells. 170
Multi-directional cross-regulation of NK cell function during innate immune responses. 170
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 170
Alloreactive natural killer cells in targeting high-risk leukaemias. 170
Human NK receptors: from the molecules to the therapy of high risk leukemias. 170
Melanoma cells become resistant to NK-cell-mediated killing when exposed to NK-cell numbers compatible with NK-cell infiltration in the tumor 169
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 169
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 169
Activity and phenotype of natural killer cells in peptide transporter (TAP)-deficient patients (type I bare lymphocyte syndrome). 169
Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. 169
Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response. 169
Human NK cells and NK receptors 168
KIR and KIR ligand polymorphism: a new area for clinical applications? 168
Role of amino acid position 70 in the binding affinity of p50.1 and p58.1 receptors for HLA-Cw4 molecules. 168
Natural killer cells and dendritic cells: rendezvous in abused tissues. 167
Comparison of different CpG oligodeoxynucleotide classes for their capability to stimulate human NK cells 167
CIS is a negative regulator of IL-15-mediated signals in NK cells 167
Activating and inhibitory killer immunoglobulin-like receptors (KIR) in haploidentical haemopoietic stem cell transplantation to cure high-risk leukaemias. 166
In vitro proliferation and cloning of CD3- CD16+ cells from human thymocyte precursors. 166
Stimulatory receptors in NK and T cells. 165
Human Natural Killer Cells exposed to IL-2, IL12, IL-18 or IL-4 differently modulate priming of naïve T cells by monocyte-derived Dendritic Cells. 165
The natural killer cell-mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94/NKG2A, but lacking inhibitory killer Ig-like receptors. 164
Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. 164
Impact of HCMV Infection on NK Cell Development and Function after HSCT. 164
Analysis of memory-like natural killer cells in human cytomegalovirus-infected children undergoing αβ+T and B cell-depleted hematopoietic stem cell transplantation for hematological malignancies 164
Cellular ligands for activating NK receptors 162
Triggering receptors involved in natural killer cell-mediated cytotoxicity against choriocarcinoma cell lines 162
Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2). 162
Surface receptors that regulate the NK cell function: beyond the NK cell scope. 161
Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis 161
CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor. 161
CD59 is physically and functionally associated with natural cytotoxicity receptors and activates human NK cell-mediated cytotoxicity 161
A monoclonal anti-DC1 antibody selectivity inhibits the generation of effector T cells mediating specific cytolytic activity. 159
Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. 159
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 159
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. 158
Uptake of CCR7 and acquisition of migratory properties by human KIR+ NK cells interacting with monocyte-derived DC or EBV cell lines: regulation by KIR/HLA-class I interaction. 158
CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. 158
Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors. 157
Cell surface expression of activating receptors and co-receptors on peripheral blood NK cells in systemic autoimmune diseases. 157
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 157
Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses 156
Unravelling natural killer cell function: triggering and inhibitory human NK receptors. 156
IL-2-mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens. 156
Totale 18.092
Salva come PNG Salva come JPEG
Categoria #
all - tutte 198.454
article - articoli 176.197
book - libri 0
conference - conferenze 7.929
curatela - curatele 0
other - altro 0
patent - brevetti 11.987
selected - selezionate 0
volume - volumi 2.341
Totale 396.908
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021562 0 0 0 0 0 0 0 0 0 0 268 294
2021/20226.108 179 498 640 659 277 297 379 1.421 220 550 259 729
2022/20235.521 631 317 52 576 895 1.118 2 397 1.014 34 410 75
2023/20242.479 123 419 69 287 229 353 107 163 194 77 145 313
2024/20257.531 126 644 317 488 1.283 711 678 991 319 342 668 964
2025/202612.174 1.447 350 787 1.045 1.613 1.553 2.362 597 830 1.212 378 0
Totale 68.313